跳至主要内容
临床试验/NCT00840151
NCT00840151已完成不适用

A SMART Design for Attendance-based Prize CM

UConn Health2 个研究点 分布在 1 个国家目标入组 360 人开始时间: 2009年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
360
试验地点
2
主要终点
longest duration of negative drug and alcohol samples submitted

研究概览

简要总结

The purpose of this study is to compare different forms of treatment for substance abuse. This study will involve a type of treatment called contingency management, in which patients receive incentives (prizes) for attending outpatient treatment. This study will compare contingency management to standard treatment that does not involve incentives. This study will also compare contingency management treatment that lasts 6 weeks to contingency management that lasts 12 weeks. Finally, this study will compare contingency management treatment delivered at the beginning of outpatient treatment to contingency management treatment delivered later during outpatient treatment. The investigators hypothesize that (1) a 12-week attendance-based contingency management intervention will improve retention and enhance drug abstinence versus standard treatment, (2) initial short-term exposure to attendance-based contingency management (in weeks 1-6 only) will improve substance abuse treatment outcomes compared to standard treatment alone, and (3) contingency management in weeks 7-12 will be particularly useful for those with sporadic attendance or continued drug use during initial stages of treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age > 18 years
  • current DSM-IV diagnosis of cocaine abuse or dependence or recent cocaine use (self-reported use in past 30 days or positive urine toxicology screen)
  • willing to sign informed consent and able to pass an informed consent quiz

排除标准

  • serious, uncontrolled psychiatric illness (e.g., acute schizophrenia, bipolar disorder, severe or psychotic major depression, or suicide risk) on the basis of history or medical examination
  • in recovery from pathological gambling (meet DSM-IV criteria for lifetime pathological gambling and are actively trying to refrain from gambling)
  • do not speak English (all treatment is provided in English at these clinics)

研究组 & 干预措施

Treatment Group A

No Intervention

Individuals randomized to Treatment Group A will receive standard treatment for study weeks 1-6.

Treatment Group B

Experimental

Individuals randomized to Treatment Group B will receive contingency management plus standard treatment for study weeks 1-6.

干预措施: contingency management (Behavioral)

Aftercare Group A

No Intervention

All participants will be re-randomized after study week 6. Those participants assigned to Aftercare Group A will receive standard treatment for study weeks 7-12.

Aftercare Group B

Experimental

All participants will be re-randomized after study week 6. Those participants assigned to Aftercare Group B will receive contingency management treatment plus standard treatment for weeks 7-12.

干预措施: contingency management (Behavioral)

结局指标

主要结局

longest duration of negative drug and alcohol samples submitted

时间窗: throughout active phase and at each follow-up assessment

次要结局

  • proportions of samples testing negative for drugs and alcohol(during active phase and at each follow-up assessment)
  • psychosocial functioning and HIV risk behaviors(baseline, active phase and at each follow-up assessment)

研究者

发起方
UConn Health
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验